CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 85 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $16,959 | -32.2% | 153,478 | 0.0% | 0.00% | – |
| Q3 2022 | $25,000 | -24.2% | 153,478 | +18.5% | 0.00% | – |
| Q2 2022 | $33,000 | -51.5% | 129,478 | +0.5% | 0.00% | – |
| Q1 2022 | $68,000 | -16.0% | 128,827 | -2.0% | 0.00% | – |
| Q4 2021 | $81,000 | -36.2% | 131,462 | +5.7% | 0.00% | – |
| Q3 2021 | $127,000 | -9.9% | 124,412 | +61.6% | 0.00% | – |
| Q2 2021 | $141,000 | -3.4% | 77,004 | +3.7% | 0.00% | – |
| Q1 2021 | $146,000 | +224.4% | 74,288 | +107.4% | 0.00% | – |
| Q4 2020 | $45,000 | +87.5% | 35,825 | +163.9% | 0.00% | – |
| Q3 2020 | $24,000 | -74.5% | 13,575 | +21.7% | 0.00% | – |
| Q2 2020 | $94,000 | -5.1% | 11,150 | -21.7% | 0.00% | – |
| Q1 2019 | $99,000 | +266.7% | 14,238 | +1.7% | 0.00% | – |
| Q1 2016 | $27,000 | – | 14,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
| ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
| Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
| Platform Technology Partners | 33,750 | $9,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
| Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
| Aries Wealth Management | 15,400 | $4,000 | 0.00% |